Katarina Steen Carlsson
51 – 60 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies
- Contribution to journal › Scientific review
-
Mark
Resource Use in Patients with Psoriasis After the Introduction of Biologics in Sweden
- Contribution to journal › Article
- 2014
-
Mark
Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.
(2014) In Diabetes therapy : research, treatment and education of diabetes and related disorders 5(2). p.591-607
- Contribution to journal › Article
-
Mark
Validation of the IHE Cohort Model of Type 2 Diabetes and the impact of choice of macrovascular risk equations
- Contribution to journal › Article
-
Mark
Health utilities of type 2 diabetes-related complications: a cross-sectional study in sweden.
- Contribution to journal › Article
-
Mark
On-demand treatment in persons with severe haemophilia
- Contribution to journal › Scientific review
-
Mark
Health Economic Analysis on a Psychosocial Intervention for Family Caregivers of Persons with Dementia.
- Contribution to journal › Article
-
Mark
Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern sweden - a population-based register study.
- Contribution to journal › Article
-
Mark
Cost-effectiveness of add-on treatments to metformin in a Swedish setting: liraglutide vs sulphonylurea or sitagplitin.
- Contribution to journal › Article
-
Mark
Childhood Health and Labor Market Outcomes in the Case of Type 1 Diabetes
(2014) In Working Paper / Department of Economics, School of Economics and Management, Lund University
- Working paper/Preprint › Working paper
